Cargando…
Mortality and Thrombosis in Injured Adults Receiving Tranexamic Acid in the Post-CRASH-2 Era
INTRODUCTION: The CRASH-2 trial demonstrated that tranexamic acid (TXA) reduced mortality with no increase in adverse events in severely injured adults. TXA has since been widely used in injured adults worldwide. Our objective was to estimate mortality and adverse events in adults with trauma receiv...
Autores principales: | Benipal, Simranjeet, Santamarina, John-Lloyd, Vo, Linda, Nishijima, Daniel K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Department of Emergency Medicine, University of California, Irvine School of Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526890/ https://www.ncbi.nlm.nih.gov/pubmed/31123544 http://dx.doi.org/10.5811/westjem.2019.4.41698 |
Ejemplares similares
-
Safety and Efficacy of Hospital Utilization of Tranexamic Acid in Civilian Adult Trauma Resuscitation
por: Neeki, Michael M., et al.
Publicado: (2020) -
Effect of Carbazochrome Sodium Sulfonate in Addition to Tranexamic Acid in Bleeding Trauma Patients
por: Okazaki, Yuka, et al.
Publicado: (2022) -
Appraising the use of tranexamic acid in traumatic and non‐traumatic intracranial hemorrhage: A narrative review
por: Jakowenko, Nicholas D., et al.
Publicado: (2022) -
Rethinking the Use of Routine Platelet Transfusions for Head Injured Patients on Antiplatelet Therapy
por: Ologun, Gabriel O, et al.
Publicado: (2019) -
Coagulopathy management of multiple injured patients – a comprehensive literature review of the European guideline 2019
por: Niemann, Marcel, et al.
Publicado: (2022)